OFI Advisors’s Pfizer PFE Stock Holding History

OFI Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$3.9M	Sell	130,773 -7,834	-6%	-$251K	0.25%	72
2015 Q2	$4.41M	Buy	138,607 +3,050	+2%	+$99.4K	0.26%	69
2015 Q1	$4.47M	Sell	135,557 -1,097	-0.8%	-$34.9K	0.26%	67
2014 Q4	$4.04M	Buy	136,654 +189	+0.1%	+$5.42K	0.26%	68
2014 Q3	$3.83M	Sell	136,465 -763	-0.6%	-$21.4K	0.27%	61
2014 Q2	$3.86M	Buy	137,228 +12,696	+10%	+$362K	0.28%	61
2014 Q1	$3.79M	Sell	124,532 -2,767	-2%	-$82.5K	0.29%	56
2013 Q4	$3.7M	Buy	127,299 +1,419	+1%	+$41.3K	0.3%	55
2013 Q3	$3.43M	Sell	125,880 -1,281	-1%	-$34.9K	0.33%	50
2013 Q2	$3.38M	Buy	+127,161	New	+$3.51M	0.35%	48

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OFI Advisors's PFE Position: Q3 2015 in Review

OFI Advisors reduced its Pfizer (PFE) stake by 5.7% in Q3 2015, selling an estimated $251K and leaving 130,773 shares worth $3.9M. The position accounts for 0.25% of the portfolio, ranked #72.

OFI Advisors first reported a position in PFE in Q2 2013 and has held it in 10 quarters since. The position peaked at $4.47M in Q1 2015. 1,879 funds tracked by Wall St. Rank hold PFE as of Q3 2015.

OFI Advisors held 130,773 shares of Pfizer worth $3.9M as of Q3 2015.
OFI Advisors sold 7,834 Pfizer shares in Q3 2015, an estimated $251K.
Pfizer made up 0.25% of OFI Advisors's portfolio in Q3 2015, its #72 holding.
OFI Advisors first reported a position in Pfizer in Q2 2013 and has held it in 10 quarters since.
OFI Advisors's Pfizer position peaked at $4.47M in Q1 2015.
1,879 funds tracked by Wall St. Rank held Pfizer as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.